Toyo Kasei's strength in dealing with a wide variety of products and multiple dosage forms

 Toyo Kasei has a factory that can handle a wide variety of multi-dosage forms, and with the support for small lots as a weapon, the corona sickness is also steadily increasing.

From skin care to make-up, we can handle multiple dosage forms such as liquid, paste, powder, stick, and colored, so even if something goes down, it is a big advantage that we can cover it with other products. There is.

"Our company tends to have the image of a make-up product, but we are also focusing on skin care and have appealed at the exhibitions so far. Although the make-up is still struggling due to the corona damage, By switching to a route that focuses on skin care, we are maximally covering the decline. "

It is said that orders for bath salts increased due to the demand for nesting in Corona. Even under these circumstances, the company flexibly responds to needs by taking advantage of its wide variety and multi-dosage forms.

In addition, eye makeup has been developed for several years, and it has been performing well due to regular use of masks. In addition, there are strong inquiries about gray hair hiding powder and hair wax. At CITE JAPAN in May this year, SPF-acquired BB cream and loose powder attracted attention.

"Recently, there seems to be an increasing need for products that are easy to express in two dimensions, such as images and videos. As for make-up, products that are quite punchy are doing well" (Mr. Hirayama)

Sales activities have also become online. Web meetings and email exchanges have increased, and in some cases new customers have been commercialized with just email.

Inquiries from new companies in different industries are also strong. There are a wide variety of manufacturers, including manufacturers in different industries with male customers, and made-in-Japan cosmetics manufacturing requests for China and Southeast Asia.

There are many requests from sole proprietors. Corona has affected not only the cosmetics industry but also various markets, but the company has been able to stably acquire a well-balanced customer base.

"In the future, we will work to further diversify risks so that we do not depend on some customers. We also believe that we must promote the development of our own technology and carry out manufacturing that can be applied to the Corona disaster. Although there are issues such as prescription disclosure, we are also considering initiatives for overseas exports, including China. "